Canlyniadau Chwilio - Jean‐Jacques Body

Mireinio'r Canlyniadau
  1. 1
    Increased fracture rate in women with breast cancer: a review of the hidden risk

    Increased fracture rate in women with breast cancer: a review of the hidden risk gan Jean‐Jacques Body

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease

    Breast Cancer: Bisphosphonate Therapy for Metastatic Bone Disease gan Jean‐Jacques Body

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN

    Epinephrine is a Hypophosphatemic Hormone in Man. PHYSIOLOGICAL EFFECTS OF CIRCULATING EPINEPHRINE ON PLASMA CALCIUM, MAGNESIUM, PHOSPHORUS, PARATHYROID HORMONE, AND CALCITONIN gan Jean‐Jacques Body, Philip E. Cryer, Kenneth P. Offord, Hunter Heath

    Cyhoeddwyd 1983
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Bone health in cancer patients: ESMO Clinical Practice Guidelines

    Bone health in cancer patients: ESMO Clinical Practice Guidelines gan Robert E. Coleman, Jean‐Jacques Body, Matti Aapro, Peyman Hadji, Jørn Herrstedt

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

    Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody gan Roger von Moos, Luís Costa, Eva González‐Suárez, Evangelos Terpos, Daniela Niepel, Jean‐Jacques Body

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

    Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer gan Komal Waqas, Joana Lima Ferreira, Elena Tsourdi, Jean‐Jacques Body, Peyman Hadji, M. Carola Zillikens

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Increased Dickkopf-1 expression in breast cancer bone metastases

    Increased Dickkopf-1 expression in breast cancer bone metastases gan Nathalie Voorzanger‐Rousselot, Delphine Goehrig, Fabrice Journé, Valérie Doriath, Jean‐Jacques Body, Philippe Clézardin, Patrick Garnero

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

    The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts gan Hichame Id Boufker, Laurence Lagneaux, Mehdi Najar, Martine Piccart, Ghanem Ghanem, Jean‐Jacques Body, Fabrice Journé

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases

    Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases gan Jean‐Jacques Body, Geoffrey C. Quinn, Susan Talbot, Emma Booth, Gaston Demonty, Aliki Taylor, Justyna Amelio

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS)

    Bariatric surgery and skeletal health: A narrative review and position statement for management by the European Calcified Tissue Society (ECTS) gan Julien Paccou, Elena Tsourdi, Christian Meier, Andrea Palermo, Jessica Pepe, Jean-Jacques Body, M. Carola Zillikens

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

    Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie... gan Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, A. F Lazarev, Martin Pecherstorfer, R. Bell, Debu Tripathy, B. Bergström

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

    Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS gan Athanasios D. Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya Khan, M. Carola Zillikens, Jean-Jacques Body

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Which treatment to prevent an imminent fracture?

    Which treatment to prevent an imminent fracture? gan Laura, Iconaru, Felicia, Baleanu, Alexia, Charles, Aude, Mugisha, Florence, Benoit, Murielle, Surquin, Rafik, Karmali, Jean-Jacques, Body, Pierre, Bergmann

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn Cael y testun llawn
    Text
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Loading and Skeletal Development and Maintenance

    Loading and Skeletal Development and Maintenance gan P. Bergmann, Jean‐Jacques Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, JM Kaufman, Jean‐Yves Reginster, Serge Rozenberg

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

    A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. gan Jean-Jacques Body, Thierry Façon, Robert E. Coleman, Allan Lipton, F. Geurs, Michelle Fan, Donna Holloway, Mark Peterson, Pirow Bekker

    Cyhoeddwyd 2006
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

    Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases gan Jean‐Jacques Body, Ingo Diel, М. Р. Личиницер, E.D. Kreuser, W. Dornoff, В. А. Горбунова, M. Budde, B. Bergström

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates

    Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates gan Karim Fizazi, Allan Lipton, Xavier Mariette, Jean‐Jacques Body, Yasmin Rahim, Julie R. Gralow, Guozhi Gao, Ling Wu, Winnie Sohn, Susie Jun

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club

    Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club gan Michaël R. Laurent, Stefan Goemaere, Charlotte Verroken, Pierre Bergmann, Jean‐Jacques Body, Olivier Bruyère, Étienne Cavalier, Serge Rozenberg, Bruno Lapauw, Evelien Gielen

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases

    Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases gan Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, Suzanne M. Jan de Beur, Seiji Fukumoto, Salvatore Minisola, Weibo Xia, Jean‐Jacques Body, M. Carola Zillikens

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

    Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride gan Hubertus I.J. Harinck, O. L. M. Bijvoet, AndréS.T. Plantingh, Jean‐Jacques Body, Jan Willem F. Elte, H.P. Sleeboom, J. Wildiers, Jan P. Neijt

    Cyhoeddwyd 1987
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: